ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,894Medicare Part D Prescriptions Filled, Including Refills

Rank: 118 out of 939

$639K Total Retail Price of All Prescriptions

Rank: 154 out of 939

425 Patients Receiving at Least One Drug in Part D
49%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

26% of this provider’s 425 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

33% of this provider’s 425 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 5,433 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 1,016 310 S3 1 1
OMEPRAZOLE 490 167 2 5
OXYCODONE HCL 457 48 S2 3 67
LISINOPRIL 353 191 4 3
ZOLPIDEM TARTRATE 330 126 5 20
LEVOTHYROXINE SODIUM 301 183 6 4
ATENOLOL 278 110 7 19
FUROSEMIDE 265 156 8 7
CARISOPRODOL 261 0 R 9 51
METFORMIN HCL 248 130 10 8
SIMVASTATIN 244 101 11 2
AMLODIPINE BESYLATE 240 103 12 6
TRAZODONE HCL 206 61 13 26
FLUOXETINE HCL 204 47 14 47
POTASSIUM CHLORIDE 198 81 15 9
OXYCODONE HCL-ACETAMINOPHEN 192 16 S2 16 107
TRAMADOL HCL 184 71 17 16
GABAPENTIN 174 66 18 11
PROMETHAZINE HCL 166 0 R 19 68
CITALOPRAM HBR 156 44 20 15
METHADONE HCL 154 41 S2 21 109
ESTRADIOL 152 29 R 22 79
BISOPROLOL-HYDROCHLOROTHIAZIDE 141 64 23 129
PROAIR HFA 140 72 24 41
OXYCODONE-ACETAMINOPHEN 137 0 S2 25 138
AMITRIPTYLINE HCL 137 27 R 25 38
GLIPIZIDE ER 133 56 27 88
KLOR-CON 10 131 81 28 158
HYDROCHLOROTHIAZIDE 125 82 29 12
NEXIUM 122 33 30 18
RANITIDINE HCL 118 45 31 35
AMOXICILLIN 115 23 32 92
CIPROFLOXACIN HCL 113 47 33 54
MELOXICAM 112 35 34 14
IBUPROFEN 111 28 35 112
CLONIDINE HCL 110 65 36 39
AZITHROMYCIN 110 39 36 32
PAROXETINE HCL 106 43 38 70
CYCLOBENZAPRINE HCL 106 23 R 38 36
METOPROLOL TARTRATE 104 43 40 10
ENDOCET 101 15 S2 41 148
SULFAMETHOXAZOLE-TRIMETHOPRIM 100 26 42 64
VENTOLIN HFA 99 35 43 80
ESCITALOPRAM OXALATE 96 34 44 61
DICLOFENAC SODIUM 91 26 45 93
WARFARIN SODIUM 90 46 46 17
CEFUROXIME 84 41 47 166
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 59 48 23
SERTRALINE HCL 81 50 49 24
FENTANYL 80 13 S2 50 104
ADVAIR DISKUS 77 54 51 60
FAMOTIDINE 77 22 51 62
FLUTICASONE PROPIONATE 76 17 53 43
AMOX TR-POTASSIUM CLAVULANATE 76 35 53 144
METOPROLOL SUCCINATE 75 41 55 21
RISPERIDONE 74 40 56 82
TRIAMCINOLONE ACETONIDE 71 28 57 150
SINGULAIR 69 18 58 101
DIOVAN 67 27 59 50
CARVEDILOL 66 31 60 25
DONEPEZIL HCL 66 48 60 30
CEPHALEXIN 65 34 62 77
LYRICA 65 26 62 63
TRIAMTERENE-HYDROCHLOROTHIAZID 64 16 64 115
CYMBALTA 63 0 65 44
POLYETHYLENE GLYCOL 3350 62 22 66 57
ATORVASTATIN CALCIUM 61 19 67 22
METHOTREXATE 60 34 68 240
DIPHENOXYLATE-ATROPINE 59 13 69 300
VENLAFAXINE HCL ER 58 0 70 121
METHOCARBAMOL 58 0 R 70 149
DIGOXIN 55 39 72 45
CELEBREX 55 31 72 106
CLOPIDOGREL 52 17 74 28
JANUVIA 51 31 75 110
PREDNISONE 51 24 75 42
GLYBURIDE 50 31 R 77 89
FLUCONAZOLE 50 0 77 140
NAPROXEN 50 28 77 72
DOXEPIN HCL 50 21 77 214
ALLOPURINOL 50 33 77 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 9, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.